Galderma Acquires ALASTIN Skincare
January 5, 2022
Galderma has completed the acquisition of ALASTIN Skincare, Inc., receiving U.S. antitrust clearance and closing the deal announced November 29, 2021. The purchase adds ALASTIN's physician-dispensed aesthetic skincare portfolio, including its patented TriHex Technology, to Galderma's integrated dermatology platform to expand product capabilities and better serve aesthetic professionals and consumers.
- Buyers
- Galderma
- Targets
- ALASTIN Skincare, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Galderma to Acquire ZO Skin Health
October 14, 2026
Consumer Products
Galderma signed an agreement to acquire 100% of ZO Skin Health from its shareholders, including funds managed by Blackstone Tactical Opportunities and the Obagi family, for an enterprise value of $1.5 billion. The acquisition is expected to expand Galderma’s physician-dispensed skincare portfolio and support ZO Skin Health’s growth through Galderma’s global reach, commercial investment, and innovation capabilities.
-
DermDox Group Acquires Modern Aesthetics Plastic Surgery
June 23, 2026
Healthcare Services
DermDox Group announced the acquisition of Modern Aesthetics Plastic Surgery, an aesthetic medicine and plastic surgery practice serving patients across Pennsylvania. The deal expands DermDox’s integrated dermatology, aesthetic medicine, and plastic surgery capabilities and adds multiple Mid-Atlantic locations under Modern Aesthetics’ name and leadership of Dr. Robert Skalicky.
-
EQT VIII Sells Galderma Group AG Shares to L'Oréal S.A.
December 8, 2025
Healthcare Services
An affiliate of EQT VIII has signed an agreement to sell approximately 24 million shares in Galderma Group AG to L'Oréal S.A. The transaction is subject to customary regulatory approvals, and the premium was not disclosed.
-
L'Oréal Acquires Skinbetter Science
September 23, 2022
Consumer Products
L'Oréal has signed an agreement to acquire Skinbetter Science, a physician-dispensed U.S. skincare brand known for dermatology-backed, clinical formulations. Skinbetter Science—headquartered in Phoenix, Arizona and reporting nearly $95 million in trailing‑12‑month sales to August 31, 2022—will be integrated into L'Oréal USA's Active Cosmetics Division while its leadership team remains in place.
-
Taro Pharmaceutical Industries Acquires Alchemee (Formerly The Proactiv Company) From Galderma
February 28, 2022
Healthcare Services
Taro Pharmaceutical Industries (NYSE: TARO) completed its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The deal transfers Alchemee’s worldwide business and assets, including the Proactiv brand, expanding Taro’s position in the over-the-counter dermatology space.
-
NovaBay Pharmaceuticals Acquires DERMAdoctor
September 28, 2021
Consumer Products
NovaBay Pharmaceuticals, Inc. has entered into a definitive agreement to acquire DERMAdoctor, LLC for $15.0 million ( $12.0 million cash at closing plus up to $3.0 million in earnouts). The deal brings DERMAdoctor's ~30-product skincare portfolio and its 13-person team (co-founders Audrey and Jeff Kunin to remain) into NovaBay's commercial platform to expand its presence in the U.S. beauty market and capture revenue and operating synergies.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.